TLR7 and non-small cell lung carcinoma: Saradiya Chatterjee et al. proved that, in patients with non-small-cell lung cancer, expression analyses revealed that high TLR7 expression was strongly associated with resistance to neoadjuvant chemotherapy and poor clinical outcomes [39].